• Arcoxia is another Cox II inhibitor drug, however, and may face renewed scrutiny as a result of the problems associated with Vioxx.

    FORBES: Merck: High-Yield Bargain Or Falling Knife?

  • And Pharmacia's new injectable COX-2 inhibitor, called Dynastat, could supplement or even supersede morphine.

    FORBES: Magazine Article

  • AstraZeneca has doped its version of a COX-2 inhibitor with nitrous oxide--laughing gas--to soften the gastrointestinal blow.

    FORBES: Magazine Article

  • Bextra, another Cox-2 inhibitor made by Pfizer, increased the risk of side effects, including heart attack in trials of patients undergoing heart surgery.

    FORBES: Pfizer's Heart Attack

  • MEDAL, he says, should be "terrific" for demonstrating whether a more powerful Cox-2 inhibitor confers more risk to the heart than a weaker one.

    FORBES: Vioxx, The Sequel

  • Nissen frets that Merck is comparing Arcoxia to diclofenac, a drug that itself is thought to be a Cox-2 inhibitor that poses some cardiovascular risk.

    FORBES: Vioxx, The Sequel

  • COX-2 inhibitor drugs, such as Celebrex, should remain on the market.

    ECONOMIST: The best medicine?

  • It was hypothesized, therefore, that a COX-2 inhibitor could be of value in eliminating these polyps and preventing colon cancer in people predisposed to such polyps.

    FORBES: Vioxx and Diclofenac: Why Are Two Heart Risky Pain Drugs Viewed Differently?

  • In early-stage human trials in May 2000, scientists observed 66% fewer stomach erosions in 31 patients treated with a nitrous oxide version of a COX-2 inhibitor versus naproxen.

    FORBES: Magazine Article

  • Six chemists spent long nights paging through piles of dusty chemistry journals in the Monsanto library to see if anyone had invented a COX-2 inhibitor without realizing it.

    FORBES: The Chemical Cobbler

  • Some supporters of a bigger government role in health care claim that drug companies often produce "me-too" medications and have cited Vioxx and Celebrex, both of the COX-2 inhibitor class.

    FORBES: Fact and Comment

  • Costa believes any new Cox-2 inhibitor could be competitive.

    FORBES: Novartis Looks To Prexige, A New Arthritis Drug

  • Now, however, there are data showing some sign of heart risk for every Cox-2 inhibitor ever approved in the U.S. Vioxx doubled the risk of heart attack and stroke in one cancer prevention study, and now the same is true for Celebrex.

    FORBES: Pfizer's Heart Attack

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定